Œ



| p



| p
  
| p






 


!


"#
| p
$
 %& 

#
| p


  
p

% '(


"#)
| p

  "

#



'
  

"
| 4
 4

p
*


!
%



  "#
p
p



 


+#
p
*
 


 
,
-

| 

   [
—
 
   —‰

· p

.

 

 %

 .

 

.
/

0


%! . 

 
1!

%% 
p
  
!
2

!


 1!




&
1!

 
   
 
.

  . /p

 
 
 

.
 

 .
%  
/
* 


—
·   
   ‰

    


    Œ‰
!
"    #$"    
# #  Π 
  
  % &

X Six members from the Teachers of pharmacy.

X Six members from practicing pharmacists or Pharmaceutical

Chemists holding degree of diploma.

X One member elected by the Medical Council of India.

X The Director-General of Health Services.

X The Director of the Central Drugs Laboratory.

X The Chief Chemist, Central Revenues.

X One member to represent each state elected by members of State
Councils who shall be a registered pharmacist.

X One member to represent each State Government who shall be

either registered medical practitioner or a registered pharmacist.

The President and Vice-President of the Central Council of

Pharmacy are elected by the members of the Council among
themselves, hold office for five years and are eligible for re-
election.

The conducting of courses of study for pharmacists, and the

examinations in Pharmacy in the states are subject to the
approval of the Central Council. Besides the Council has the
responsibility to supervise the Education of Pharmacy in the
States. Where it is found that the course of study is not in
conformity with the Education Regulations, the Council may
withdraw approval accorded to the course or the examination.
The Central Council can approve qualifications granted by an
outside authority for qualifying for registration under this Act
4 #  
The Act makes it incumbent upon the State Governments to
constitute State Pharmacy Councils with the following members:

a) Six members elected from amongst themselves by registered

Pharmacists of the state.

b) Five members of whom at least two shall be persons possessing a

prescribed degree or diploma in Pharmacy or Pharmaceutical
Chemistry or members of the Pharmaceutical profession
nominated by the State Government.

c) One member elected by the State Medical Council.

d) The Chief Medical Officer of the State.

e) The State Drug Controller.

f) The Government Analyst.


     
p





 


 


  





  





  
   





p


 










  

 
 



 
 

 
  










 
   
≠p

 




 




 

p 
   


!




 
3% 


!
 .






%
 4 

%!

. 






5 /
p





% %
 . + % %  
. 
!



.
  
5  

.

.6

¢
 


 



 












¢





  




 


 

 


¢




  




¢






 











   

 






 


  
  !

  




 


 



    "


  
 
  

 









 


è 


 



 
  





 
  


  



     




 





 












 p
 

 
  
  













#









 




 







 







  


 



 



 

p
  


 

$¢

  







 


 




 




¢


 !

 


 






¢







 










 

 
 
  





 

     

¢








! 

 
  
 —

p    






5
 $ +

 
%! .
  


  .%
 
 $

 %& 

.






5 /
· &7'08'9:;7p*p<'&$*p&--'p$
7'0p*8*$0&p9*$*$*
| ; &7'08'9[


4





.%
  
 %
=  .
.
5

.


+
    


.

>>>>2>>>>

>>
>>'
 p?.@08'&#

>>A%%  .%
   %
5


>>A2%%  .%%!   .


5

>>A



>>A
   %  .
-

>>A
  
    .
$
5=* !
  $
5
 8*$*8p*8

>>A
B    C
 

.
5

"    
"



.

!
 
=!
. 
   
%      
 %  
  

%  +
"
=
!


..

5 

!
.


   .

=

...

5
/
 $';01

>>A'/
A $



 
 

 
 

 
A %%!

 5%%


 +



5  
.


5  :
 




. 
.
 
A -
!
 %%!


 

.

.
 .(

.
  

 *$<'&p*1p*$8$';01

$
5
 
%

 ! 

%

 5   

!



 



    

 

O <


5



5


.

O  




5
.

    *
· '&$&*2*8*p*'&-&$&*$<'&p*1p$
'p7*&*p''
 r %" & ' p %(p) %"%r

X * %

 
    4  

Aü


!ü "ü  

&*$*
X &% 

4

 
% 
    

8
  
%


%

!

"
X * 
.

%


  

. 
   
 
+.
  

 % 

5
%%  
 
% 

 

5  â /p
 

% 
%!


.

% .


  
.
%

(%







 .
(%


 
.
!



 


 .
   .


  A%.

5
%% 
X  
(%


 # $#!$¢

.

 1
1


" 
      

  


% % º—


 "
&% 
8
 
 


* !
"%%  

/
 „ ( " p %" *„r* *„r

r SAE / SADR$





*




 

 


 
 

 



 

 




 
  

 








r Adverse Event (AE ) $


 



+
 

*

 

 

¢ 



 
  
  


  



 





  


  









r Adverse Drug Reaction (ADR) :

-  
  $" *









  

 


 

- ,
 
  $" *










- p




 







 


   

 r %" & ' p %( "- p p%r

X
% 
.


.
 
 

% 

ü ü  
 . %  
/
X


 

4








 !
.
+%
.



/
X' 
 
%


%!




%% . 
!


!
/
X
%   
&
# # 

&% 5  *  

'  

 



%%! 

% 5  -º'

 .


/
 r %" & ' p %( p) %.. pp

| 
(
 .

5

 .  

/
|  
%

 .

5

 
.
# 
  ) 
|  o 


 * 
   



| =#º

 %


%

%
| * 
 
  

#' %%!  




 .
 
 
  

 

 
* !

º 

+ 
· 8*p*$-'*&&*$0$'-'1080p7*p*'&-'&&$
p'&p8*'$'
 REGULATORY AUTHORITIES
. " pr
%() . .
 )
  .
 
/( rp ' 0 r )
 


/
p


HealthSecretory .
 

 



NPPA DBT
(National #$4 (Department of
Pharmaceutical $  Biotechnology)
Pricing Authority) 4" ¢ Additional
Secretary
#$Œ

#$ GEAC
 Π(Genetic
j  
Engineering

  CDL/CDTL
Approval
Gov. Drug Testing
Committee)
Laboratories

State Drug Regulatory Authority :FDA

 r% 
r%-'(%r.12
+ .((¢
' p %"
(%r.11
r%-'(%r.12
4  + .r.¢
4  
4. r%-'(%r.13+.(
((¢
4. 
4p ' p %"(%r.13+.(
r.¢

NOC FOR CT + Test

Licence for Import
 ( 
* %..=...=* % +D...E#=
.
5

%%  
%%  E#=A
. 
.



. 5 
5 
&

%%  .
E#=A

.%%!
* %=.-E#=A

    5 $=*$
: 
*E#=A
: 
**E>#=A
: 
***E>#=A
$
%
.


%
  5 %%  .
 %= .

 
.  %

 8*p*$*$-
D 

4  **** ****¢
%%  . .%
   %  .
$
5


+
   
*=;
//FFF//.FFF//

%% . .%
  . %

=    .%%!   .
.
5

.(



   
4
%
  . 

%%!



5
/p


 .  =
!

56
/ .$
56
· $
.

6
· 
- 6
·  % .
.   6
· p
%
. 6
O !
 


6
O * !
 


6
·      . .

6
· *
 .5  %%




6
·  .
.
5 
 6
· 

 - 

* 

 
º
 

  
'º
‰ #     
*‰   

'‰  (

‰  )# 

‰ (
#
‰ #  # 
‰ "%)   %
‰ 
    
‰
*
  &
¢
 
  


%¢   % 
+‰ 

   &
 - 

 %
#
, (
(
(



#º
¢D &
¢ "%)%, "
%¢-  " 
)
¢4    %

%¢

š
  


š.#
  
  %
š (

#
, (-
‰/  
*‰0*)0 
'‰
 - 

 %
#

#
(º

.º
(/
š- % 

"

š/  
š   , 

   1111111 %

$"    11

 ¢
4
 
 


 4Œ#-#



&

| D *


|
/  
|  #  ++   

% + 

|  %D